Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned that we are facing an antibiotic crisis. Bacteria can easily adapt, evolve, ...

Scientists from the University of Tübingen and Monash University studied glycopeptide antibiotics, a key resource in countering drug-resistant pathogens, to uncover their evolutionary origins to gain ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

With nearly 5 million deaths linked to antibiotic resistance globally every year, new ways to combat resistant bacterial strains are urgently needed. Researchers at Stanford Medicine and McMaster ...

Although the past decade has been marked by lack of innovation in the field of antibiotics development, that trend is changing, according to data from Reportlinker. According to the data, 109 ...

InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...

The Department of Health and Human Services has announced funding for antibiotic research and development using Generative AI. The stop Emerging Threats (TARGET), through the Advanced Research ...

Scientists from the University of Illinois Chicago and Harvard University have announced the development of a potent new antibiotic that could revolutionize the fight against drug-resistant bacteria.

DENVER The last time a new tuberculosis drug was developed, Richard Nixon was in the White House. That drug, Rifampin, "was the biggest thing to hit TB in 30 years," said Dr. Michael Iseman, a ...

Gram-negative bacteria, notorious for their antibiotic resistance, possess a formidable defense mechanism in the form of lipopolysaccharides (LPS). These large molecules, consisting of fatty acyl ...

Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. The latest program to be discontinued is SPR206, a next-gen polymyxin that ...

This is the first study to find a positive association between antibiotic use and subsequent CD. Antibiotic exposure was also linked to small-intestinal inflammation and to normal mucosa with positive ...